Using manufacturing simulation to optimize pharma plant design

The pharmaceutical industry faces mounting pressure to develop and produce medicines faster while maintaining strict quality standards and managing rising costs. Two key trends are driving this challenge: the explosive growth of personalized medicine (expected to more than double from $512 billion to $1.1 trillion by 2032) and the dramatic increase in drug development projects (rising 145% from about 10,000 to nearly 24,000 drugs in the pipeline between 2010 and 2025). Traditional manufacturing methods, which rely on paper-based processes and disconnected systems, simply cannot keep up with these demands.

By utilizing simulation technology, companies can create virtual replicas of manufacturing plants, enabling them to test production scenarios, identify bottlenecks and validate designs before physical implementation. This approach significantly reduces time and costs while improving equipment efficiency from 35% to 60% through optimized workflows, reduced breakdowns and faster changeover times.

The shift toward smart manufacturing transforms traditional facilities into intelligent, self-optimizing systems powered by AI and robotics. With the digital twin market growing 30% annually through 2032 and 92% of manufacturing leaders identifying smart manufacturing as critical for competitiveness, simulation technology has become the essential driver of pharmaceutical industry transformation.

View the infographic to learn more.